Skip to content

AOCI at other companies

Pfizer logo
PfizerPFE
-$7.2B+16.1%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$121K-456%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$8.47M+161%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$2.52M-29.3%
Vericel logo
VericelVCEL
-$168K-224%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$137K-157%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$1.71B+303%
Enterprise value$1.62B+308%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's AOCI?
Capricor Therapeutics (CAPR) reported AOCI of -$253.73K in Q1 2026.
How has Capricor Therapeutics's AOCI changed year-over-year?
Capricor Therapeutics's AOCI decreased by 114.0% year-over-year, from $1.81M to -$253.73K.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.